Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Better Dividend Stock: AbbVie or Pfizer?

TheMotleyFool

0 0

Better Dividend Stock: AbbVie or Pfizer?Photo, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png

If you're looking for juicy dividend yields, you might want to check out big pharmaceutical stocks. AbbVie (NYSE: ABBV) and Pfizer (NYSE: PFE) stand out as two of the best in the industry.

So far this year, Pfizer has been the bigger winner in terms of stock performance . However, over the past decade, AbbVie has delivered a much greater total return than Pfizer has.

Which of these two pharma giants is the better dividend stock to buy right now? Here's how AbbVie and Pfizer stack up against each other.

Source Fool.com

Like: 0

ABBV

Share